What is really amazing is what Linda Powers has up her sleeve. She isn’t talking about some things going on in research with others that had received some previous attention in the past. The key to understanding where things might be heading is in what is not being talked about or even hinted at any more with this company. So so much to be shared at the right time. Their research is much further ahead of being able to capitalize on it because of “the process” right now. Once manufacturing gets taken care of, that trump card will push regulators faster and further ahead so costs can be driven down than many have thought possible because of the concept of “sameness” and specific biomarkers related to survival. This is going to be fun to watch unfold. First things first. It’s Dr. Linda Liau time. Best wishes.
Market Data 
Markets 
AI
